{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:31:08Z","timestamp":1786980668065,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s10384-008-0536-8","type":"journal-article","created":{"date-parts":[[2008,11,9]],"date-time":"2008-11-09T20:37:39Z","timestamp":1226263059000},"page":"393-398","source":"Crossref","is-referenced-by-count":19,"title":["Upregulation of tumor necrosis factor receptor 1 and TNF-\u03b1 converting enzyme during corneal wound healing"],"prefix":"10.1007","volume":"52","author":[{"given":"Tohru","family":"Sakimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,1]]},"reference":[{"key":"536_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1074-7613(01)00215-1","volume":"15","author":"S.R. Ruuls","year":"2001","unstructured":"Ruuls SR, Hoek RM, Ngo VN, et al. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 2001;15:533\u2013543.","journal-title":"Immunity"},{"key":"536_CR2","first-page":"1744","volume":"39","author":"R.R. Pfister","year":"1998","unstructured":"Pfister RR, Haddox JL, Sommers CI. Injection of chemoattractants into normal cornea: a model of inflammation after alkali injury. Invest Ophthalmol Vis Sci 1998;39:1744\u20131750.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3Suppl","key":"536_CR3","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/00003226-200005001-00003","volume":"19","author":"S.E. Wilson","year":"2000","unstructured":"Wilson SE. Role of apoptosis in wound healing in the cornea. Cornea 2000;19(3 Suppl):S7\u201312.","journal-title":"Cornea"},{"key":"536_CR4","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.2353\/ajpath.2006.050980","volume":"168","author":"S. Saika","year":"2006","unstructured":"Saika S, Ikeda K, Yamanaka O, et al. Loss of tumor necrosis factor alpha potentiates transforming growth factor beta-mediated pathogenic tissue response during wound healing. Am J Pathol 2006;168:1848\u20131860.","journal-title":"Am J Pathol"},{"key":"536_CR5","first-page":"2795","volume":"42","author":"J.W. Hong","year":"2001","unstructured":"Hong JW, Liu JJ, Lee JS, et al. Proinflammatory chemokine induction in keratocytes and inflammatory cell infiltration into the cornea. Invest Ophthalmol Vis Sci 2001;42:2795\u20132803.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"536_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrm1548","volume":"6","author":"C.P. Blobel","year":"2005","unstructured":"Blobel CP. ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 2005;6:32\u201343.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"536_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/385729a0","volume":"385","author":"R.A. Black","year":"1997","unstructured":"Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997;385:729\u2013733.","journal-title":"Nature"},{"key":"536_CR8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/385733a0","volume":"385","author":"M.L. Moss","year":"1997","unstructured":"Moss ML, Jin SL, Milla ME, et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997;385:733\u2013736.","journal-title":"Nature"},{"key":"536_CR9","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1126\/science.282.5392.1281","volume":"282","author":"J.J. Peschon","year":"1998","unstructured":"Peschon JJ, Slack JL, Reddy P, et al. An essential role for ectodomain shedding in mammalian development. Science 1998;282:1281\u20131284.","journal-title":"Science"},{"key":"536_CR10","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1083\/jcb.200307137","volume":"164","author":"U. Sahin","year":"2004","unstructured":"Sahin U, Weskamp G, Kelly K, et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004;164:769\u2013779.","journal-title":"J Cell Biol"},{"key":"536_CR11","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1002\/1521-4141(2002010)32:10<2965::AID-IMMU2965>3.0.CO;2-V","volume":"32","author":"V. Marin","year":"2002","unstructured":"Marin V, Montero-Julian F, Gres S, et al. Chemotactic agents induce IL-6Ralpha shedding from polymorphonuclear cells: involvement of a metalloproteinase of the TNF-alpha-converting enzyme (TACE) type. Eur J Immunol 2002;32:2965\u20132970.","journal-title":"Eur J Immunol"},{"key":"536_CR12","doi-asserted-by":"publisher","first-page":"14608","DOI":"10.1074\/jbc.275.19.14608","volume":"275","author":"P. Reddy","year":"2000","unstructured":"Reddy P, Slack JL, Davis R, et al. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 2000;275:14608\u201314614.","journal-title":"J Biol Chem"},{"key":"536_CR13","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1046\/j.1432-1327.2000.01278.x","volume":"267","author":"K. Althoff","year":"2000","unstructured":"Althoff K, Reddy P, Voltz N, et al. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins. Eur J Biochem 2000;267:2624\u20132631.","journal-title":"Eur J Biochem"},{"key":"536_CR14","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1073\/pnas.89.11.4845","volume":"89","author":"K.J. Zee Van","year":"1992","unstructured":"Van Zee KJ, Kohno T, Fischer E, et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A 1992;89:4845\u20134849.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"536_CR15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.4049\/jimmunol.176.2.721","volume":"176","author":"D.S. Smookler","year":"2006","unstructured":"Smookler DS, Mohammed FF, Kassiri Z, et al. Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol 2006;176:721\u2013725.","journal-title":"J Immunol"},{"key":"536_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","volume":"97","author":"M.F. McDermott","year":"1999","unstructured":"McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999;97:133\u2013144.","journal-title":"Cell"},{"key":"536_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1042\/bj3210265","volume":"321","author":"N.M. Hooper","year":"1997","unstructured":"Hooper NM, Karran EH, Turner AJ. Membrane protein secretases. Biochem J 1997;321 (Pt 2):265\u2013279.","journal-title":"Biochem J"},{"key":"536_CR18","first-page":"2430","volume":"40","author":"C. Sotozono","year":"1999","unstructured":"Sotozono C, He J, Tei M, et al. Effect of metalloproteinase inhibitor on corneal cytokine expression after alkali injury. Invest Ophthalmol Vis Sci 1999;40:2430\u20132434.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"536_CR19","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.biocel.2006.03.010","volume":"38","author":"J.A. West-Mays","year":"2006","unstructured":"West-Mays JA, Dwivedi DJ. The keratocyte: corneal stromal cell with variable repair phenotypes. Int J Biochem Cell Biol 2006;38:1625\u20131631.","journal-title":"Int J Biochem Cell Biol"},{"key":"536_CR20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1350-9462(01)00008-8","volume":"20","author":"S.E. Wilson","year":"2001","unstructured":"Wilson SE, Mohan RR, Mohan RR, et al. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res 2001;20:625\u2013637.","journal-title":"Prog Retin Eye Res"},{"key":"536_CR21","doi-asserted-by":"publisher","first-page":"21751","DOI":"10.1074\/jbc.M212662200","volume":"278","author":"J. Wang","year":"2003","unstructured":"Wang J, Al-Lamki RS, Zhang H, et al. Histamine antagonizes tumor necrosis factor (TNF) signaling by stimulating TNF receptor shedding from the cell surface and Golgi storage pool. J Biol Chem 2003;278:21751\u201321760.","journal-title":"J Biol Chem"},{"key":"536_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1043-4666(03)00117-0","volume":"22","author":"M. Ermert","year":"2003","unstructured":"Ermert M, Pantazis C, Duncker HR, et al. In situ localization of TNFalpha\/beta, TACE and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue. Cytokine 2003;22:89\u2013100.","journal-title":"Cytokine"},{"key":"536_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1074-7613(01)00215-1","volume":"15","author":"S.R. Ruuls","year":"2001","unstructured":"Ruuls SR, Hoek RM, Ngo VN, et al. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 2001;15:533\u2013543.","journal-title":"Immunity"},{"key":"536_CR24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1096\/fj.01-0776com","volume":"16","author":"R. Mori","year":"2002","unstructured":"Mori R, Kondo T, Ohshima T, et al. Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J 2002;16:963\u2013974.","journal-title":"FASEB J"},{"key":"536_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1084\/jem.20040435","volume":"200","author":"S. Xanthoulea","year":"2004","unstructured":"Xanthoulea S, Pasparakis M, Kousteni S, et al. Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases. J Exp Med 2004;200:367\u2013376.","journal-title":"J Exp Med"},{"key":"536_CR26","first-page":"27","volume":"146","author":"J.R. Bradley","year":"1995","unstructured":"Bradley JR, Thiru S, Pober JS. Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol 1995;146:27\u201332.","journal-title":"Am J Pathol"},{"key":"536_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0609.1995.tb01618.x","volume":"54","author":"A. Diez-Ruiz","year":"1995","unstructured":"Diez-Ruiz A, Tilz GP, Zangerle R, et al. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995;54:1\u20138.","journal-title":"Eur J Haematol"},{"key":"536_CR28","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1167\/iovs.06-1444","volume":"48","author":"S. Sugita","year":"2007","unstructured":"Sugita S, Takase H, Taguchi C, Mochizuki M. The Role of Soluble TNF Receptors for TNF-{alpha} in Uveitis. Invest Ophthalmol Vis Sci 2007;48:3246\u20133252.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"536_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S1359-6101(96)00026-3","volume":"7","author":"D. Aderka","year":"1996","unstructured":"Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 1996;7:231\u2013240.","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-008-0536-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-008-0536-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-008-0536-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-008-0536-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T12:20:00Z","timestamp":1559132400000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-008-0536-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1007\/s10384-008-0536-8","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}